2m 2m 2m 2m 2m 2m 2m
Biocryst Pharm (BCRX)
NASDAQ
$9.28+$0.14 (+1.49%)
Price as of Jun 23, 2026 6:33 PM EDT- $2.3BMarket Cap
- -7.77%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Biocryst Pharm (BCRX)
$9.28+$0.14 (+1.49%)
Earnings Score
Valuation | BCRX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | BCRX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -4.59% | ||
12-Month Momentum | -13.47% | ||
3-Month Risk Adjusted Momentum | -22.84% | ||
12-Month Risk Adjusted Momentum | -31.33% |
True Yield
Valuation | BCRX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -1.10% | ||
Net Debt Paydown Yield | -22.39% |
Financial Health Score
Valuation | BCRX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |